A new systematic review shows that nasal spray adrenaline (via liquid or powder sprays) can be as fast or faster than injections for treating anaphylaxis, a possible needle-free alternative to EpiPen®.
H2 has a rich history dating back to its discovery in the 18th century. Research on its biological safety lagged until a 2007 study revealed its antioxidant effects, particularly its ability to neutralise harmful hydroxyl radicals. Alexander Nenov discusses H2’s potential as a tool to support overall wellbeing.
A new gene therapy called AMT-130 has shown promising results in slowing the progression of Huntington’s disease, according to the latest results from a global clinical trial.
UCSF researchers report a new spatial repellent that provides up to one year of protection against malaria and other mosquito-borne diseases, marking the first WHO-endorsed vector control tool in over four decades.
Drs Francesc Xavier Cos Claramunt and Carmen Hurtado, representatives of the European Diabetes Forum (EUDF), discuss the prevalence and challenges associated with diabetes management and the health-related policies needed to support prevention and early diagnosis.
NICE has endorsed idebenone (Raxone) on the NHS to treat Leber’s hereditary optic neuropathy in individuals aged 12 and over, offering hope to around 250 people.
Oxyhydrogen is a mixture of hydrogen and oxygen produced through water electrolysis. Inhalation offers therapeutic benefits, often delivered via nasal cannulas or masks. Recent research highlights molecular hydrogen (H2) as a powerful antioxidant with anti-inflammatory properties; Alexander Nenov from Water Fuel Engineering explains.
A breakthrough treatment for severe hay fever caused by birch pollen will soon be available on the NHS, as NICE recommends the first daily immunotherapy tablet for patients who don’t respond to standard therapies.
The UK has approved its first-ever needle-free adrenaline treatment for severe allergic reactions, marking a major development in how anaphylaxis could be managed in emergencies.
Adam Mence from L&R Medical UK walks us through rebalancing wound care, explaining the challenge of overusing sub-therapeutic compression through evidence-based pathways.
Estonia is leading in integrating genomic data into national healthcare, showcasing a model for personalised medicine as essential for sustainable healthcare, particularly for conditions like depression and breast cancer.
BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.
